Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Daniel Pollyea

Concepts (487)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
121
2026
700
26.590
Why?
Bridged Bicyclo Compounds, Heterocyclic
45
2026
291
11.000
Why?
Sulfonamides
45
2026
592
9.650
Why?
Antineoplastic Combined Chemotherapy Protocols
54
2026
1996
8.180
Why?
Myelodysplastic Syndromes
31
2026
170
6.850
Why?
Azacitidine
25
2026
168
6.450
Why?
Antineoplastic Agents
26
2026
2218
3.380
Why?
Mutation
37
2026
4082
2.990
Why?
Isocitrate Dehydrogenase
13
2022
71
2.750
Why?
Hematologic Neoplasms
10
2023
169
2.590
Why?
Neoplasm, Residual
8
2026
143
2.360
Why?
Neoplastic Stem Cells
15
2025
402
2.290
Why?
Hematopoietic Stem Cell Transplantation
17
2024
700
2.070
Why?
Triazines
7
2021
48
1.820
Why?
Aminopyridines
7
2021
128
1.750
Why?
Remission Induction
16
2026
308
1.640
Why?
Prognosis
31
2026
4331
1.580
Why?
Neoplasm Recurrence, Local
6
2025
1156
1.570
Why?
Graft vs Host Disease
9
2024
280
1.550
Why?
Humans
169
2026
145625
1.370
Why?
RNA Splicing Factors
3
2020
66
1.340
Why?
Aged
65
2026
26251
1.330
Why?
Aged, 80 and over
35
2026
8351
1.310
Why?
Treatment Outcome
37
2026
11744
1.200
Why?
Phosphoproteins
3
2020
319
1.180
Why?
Cytarabine
8
2022
66
1.150
Why?
Leukemia
4
2023
246
1.040
Why?
Middle Aged
54
2026
36359
0.960
Why?
Salvage Therapy
5
2023
163
0.940
Why?
Immunotherapy, Adoptive
3
2025
356
0.930
Why?
Clonal Evolution
2
2017
47
0.920
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2025
7
0.920
Why?
Cord Blood Stem Cell Transplantation
4
2024
103
0.900
Why?
DNA Methylation
5
2026
721
0.870
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2022
76
0.830
Why?
fms-Like Tyrosine Kinase 3
4
2017
51
0.830
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2023
299
0.810
Why?
Drug Resistance, Neoplasm
9
2025
889
0.810
Why?
Nuclear Proteins
5
2018
739
0.810
Why?
Histocompatibility Antigens Class I
1
2025
207
0.800
Why?
Molecular Targeted Therapy
7
2024
446
0.780
Why?
Carrier Proteins
3
2017
728
0.770
Why?
Transplantation Conditioning
9
2024
191
0.760
Why?
Leukemia, Neutrophilic, Chronic
3
2019
5
0.750
Why?
Male
64
2026
73014
0.750
Why?
Female
69
2026
79080
0.730
Why?
Thrombocytopenia
2
2023
205
0.730
Why?
Spliceosomes
2
2020
54
0.720
Why?
Dancing
1
2022
19
0.720
Why?
Adult
40
2026
40821
0.710
Why?
Proto-Oncogene Proteins c-bcl-2
4
2018
237
0.690
Why?
Enzyme Inhibitors
5
2020
820
0.690
Why?
Anemia
2
2020
189
0.680
Why?
Febrile Neutropenia
1
2020
6
0.660
Why?
Splicing Factor U2AF
2
2023
18
0.630
Why?
Receptors, Colony-Stimulating Factor
2
2017
7
0.600
Why?
T-Lymphocytes
2
2025
2007
0.600
Why?
Serine-Arginine Splicing Factors
2
2019
27
0.600
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
2025
128
0.590
Why?
Phenylurea Compounds
7
2020
122
0.550
Why?
Signal Transduction
11
2026
5234
0.550
Why?
Staurosporine
1
2017
22
0.530
Why?
Stem Cells
3
2020
612
0.530
Why?
Benzimidazoles
6
2020
189
0.500
Why?
Gene Frequency
2
2017
495
0.480
Why?
Protein Kinase Inhibitors
10
2025
982
0.470
Why?
Monocytes
2
2018
538
0.460
Why?
Neoplasms, Plasma Cell
1
2015
5
0.460
Why?
Recurrence
9
2023
1125
0.460
Why?
Leukocytosis
1
2015
31
0.460
Why?
Skin Neoplasms
1
2023
805
0.460
Why?
Glycine
4
2021
184
0.450
Why?
Gene Expression
1
2020
1461
0.450
Why?
High-Throughput Nucleotide Sequencing
2
2018
538
0.450
Why?
Retrospective Studies
17
2026
17291
0.420
Why?
Epigenesis, Genetic
1
2019
705
0.420
Why?
Maximum Tolerated Dose
5
2019
216
0.420
Why?
Precision Medicine
1
2018
462
0.410
Why?
Oxidative Phosphorylation
6
2024
212
0.410
Why?
Computational Biology
1
2019
675
0.410
Why?
Hematopoietic Stem Cells
4
2026
432
0.410
Why?
Patient Safety
1
2018
351
0.410
Why?
Young Adult
17
2026
14240
0.400
Why?
Clinical Trials, Phase I as Topic
2
2024
49
0.400
Why?
Apoptosis
4
2018
2436
0.400
Why?
Pyridines
5
2023
606
0.400
Why?
Induction Chemotherapy
3
2024
87
0.400
Why?
Clinical Trials, Phase III as Topic
2
2024
116
0.390
Why?
Hematopoiesis
4
2020
195
0.390
Why?
Medical Oncology
4
2023
344
0.390
Why?
Neoplasm Proteins
4
2022
443
0.390
Why?
Neoplasms
5
2025
2944
0.380
Why?
Dose-Response Relationship, Drug
7
2021
2018
0.370
Why?
Immunity, Innate
1
2019
843
0.370
Why?
Pyrazoles
1
2017
516
0.370
Why?
Germ-Line Mutation
3
2022
180
0.370
Why?
Leukemia, Myeloid
1
2012
49
0.370
Why?
Mitochondria
4
2025
996
0.370
Why?
Glutarates
1
2012
11
0.370
Why?
DNA (Cytosine-5-)-Methyltransferases
2
2018
37
0.350
Why?
STAT3 Transcription Factor
2
2025
214
0.350
Why?
Biomarkers, Tumor
5
2025
1334
0.350
Why?
Survival Rate
11
2025
2078
0.340
Why?
RNA Splicing
4
2023
287
0.330
Why?
Neutrophils
2
2023
1132
0.330
Why?
United States Food and Drug Administration
2
2022
207
0.330
Why?
Drug Delivery Systems
1
2014
377
0.320
Why?
Follow-Up Studies
8
2020
5397
0.320
Why?
Cytokines
5
2026
2079
0.320
Why?
Aldehyde Dehydrogenase
3
2017
98
0.320
Why?
Antibodies, Monoclonal, Humanized
7
2023
992
0.310
Why?
Leukocyte Count
2
2024
319
0.310
Why?
Rhipicephalus sanguineus
1
2009
1
0.310
Why?
Triatoma
1
2009
7
0.310
Why?
Insect Bites and Stings
1
2009
13
0.310
Why?
Risk Assessment
6
2026
3678
0.300
Why?
Wasps
1
2009
23
0.300
Why?
Syncope
1
2009
48
0.300
Why?
Electron Transport Complex II
2
2019
27
0.290
Why?
Mutant Proteins
2
2019
103
0.280
Why?
Kaplan-Meier Estimate
5
2020
959
0.280
Why?
Proto-Oncogene Proteins
2
2018
615
0.280
Why?
Cell Self Renewal
2
2019
50
0.280
Why?
Influenza A Virus, H1N1 Subtype
1
2010
161
0.280
Why?
Anaphylaxis
1
2009
105
0.270
Why?
Acute Disease
3
2023
1033
0.270
Why?
Administration, Oral
4
2018
867
0.270
Why?
Bone Marrow
4
2017
308
0.270
Why?
Transplantation, Homologous
6
2022
415
0.260
Why?
Niacinamide
2
2026
103
0.260
Why?
Animals
29
2026
38030
0.260
Why?
Survival Analysis
6
2020
1372
0.260
Why?
Gene Expression Regulation, Leukemic
3
2016
56
0.260
Why?
Randomized Controlled Trials as Topic
3
2024
1754
0.260
Why?
Drug Administration Schedule
4
2020
782
0.250
Why?
Disease-Free Survival
5
2022
777
0.250
Why?
Sarcoma, Myeloid
1
2026
6
0.240
Why?
Mice
20
2026
18266
0.240
Why?
Primary Myelofibrosis
2
2016
8
0.240
Why?
Thrombocythemia, Essential
2
2016
7
0.240
Why?
Polycythemia Vera
2
2016
9
0.230
Why?
Cytogenetic Analysis
2
2022
34
0.230
Why?
ras Proteins
1
2026
148
0.220
Why?
Voltage-Dependent Anion Channel 1
1
2025
15
0.220
Why?
Hematopoietic Cell Growth Factors
1
2025
5
0.220
Why?
Clinical Trials as Topic
4
2020
1062
0.220
Why?
Phenotype
3
2025
3186
0.220
Why?
Influenza Vaccines
1
2010
541
0.220
Why?
DEAD-box RNA Helicases
2
2015
89
0.210
Why?
Transplantation, Haploidentical
1
2024
23
0.210
Why?
Tumor Microenvironment
2
2026
745
0.200
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2025
158
0.200
Why?
Stem Cell Transplantation
3
2023
189
0.200
Why?
Influenza, Human
1
2010
634
0.200
Why?
Azetidines
1
2024
45
0.200
Why?
Allografts
2
2021
148
0.200
Why?
Finland
1
2023
72
0.190
Why?
DNA Mutational Analysis
4
2019
409
0.190
Why?
Down-Regulation
1
2025
612
0.190
Why?
DNA-Binding Proteins
1
2010
1467
0.190
Why?
Drug Therapy, Combination
4
2022
1034
0.190
Why?
Time-to-Treatment
1
2025
257
0.190
Why?
Antibodies, Neoplasm
3
2007
34
0.190
Why?
Antibodies, Monoclonal
4
2017
1511
0.190
Why?
Disease Management
4
2021
649
0.190
Why?
Uncertainty
1
2023
145
0.180
Why?
Interleukin-3 Receptor alpha Subunit
2
2019
17
0.180
Why?
RNA, Messenger
1
2010
2783
0.180
Why?
Piperidines
1
2024
223
0.180
Why?
Myeloproliferative Disorders
1
2022
21
0.180
Why?
Hematology
1
2022
21
0.180
Why?
Proto-Oncogene Proteins c-myc
2
2022
157
0.180
Why?
Amino Acid Transport System ASC
1
2022
12
0.180
Why?
Thalidomide
2
2012
43
0.180
Why?
Succinate Dehydrogenase
2
2019
65
0.170
Why?
Minor Histocompatibility Antigens
1
2022
47
0.170
Why?
Lymphoma, Non-Hodgkin
1
2023
124
0.170
Why?
Calcium
2
2025
1181
0.170
Why?
Disease Progression
3
2023
2857
0.170
Why?
Receptors, Mitogen
1
2021
7
0.170
Why?
Cell Line, Tumor
8
2025
3538
0.170
Why?
Polymerase Chain Reaction
1
2024
1030
0.170
Why?
Lectins, C-Type
1
2021
61
0.160
Why?
Blood Cell Count
1
2020
56
0.160
Why?
Erythroblasts
1
2020
18
0.160
Why?
Cell Transformation, Neoplastic
3
2018
314
0.160
Why?
Lipids
1
2025
715
0.160
Why?
Inflammation Mediators
2
2020
507
0.160
Why?
Histocompatibility Testing
2
2019
122
0.150
Why?
Lipase
1
2020
76
0.150
Why?
Tumor Lysis Syndrome
1
2019
10
0.150
Why?
United States
6
2025
16041
0.150
Why?
Cell Survival
5
2025
1102
0.150
Why?
Dendritic Cells
1
2023
507
0.150
Why?
Chemical and Drug Induced Liver Injury
1
2021
138
0.150
Why?
Leukopoiesis
1
2019
11
0.150
Why?
Immunoconjugates
1
2021
138
0.150
Why?
NADPH Oxidase 2
1
2019
32
0.150
Why?
Myeloid Progenitor Cells
1
2019
16
0.150
Why?
NF-kappa B p50 Subunit
1
2019
22
0.140
Why?
Age Factors
5
2022
3321
0.140
Why?
K562 Cells
1
2019
93
0.140
Why?
RAW 264.7 Cells
1
2019
51
0.140
Why?
Tricarboxylic Acids
1
2018
11
0.140
Why?
Fatty Acids
2
2020
460
0.140
Why?
Ketoglutaric Acids
1
2018
22
0.140
Why?
Genetic Testing
2
2019
491
0.140
Why?
Mycoses
1
2019
86
0.140
Why?
Hematologic Diseases
1
2019
66
0.140
Why?
Antibodies
1
2021
395
0.140
Why?
Tumor Suppressor Protein p53
1
2022
530
0.140
Why?
Mitochondrial Proteins
2
2018
263
0.140
Why?
Genomics
3
2019
851
0.140
Why?
Thiotepa
1
2018
21
0.140
Why?
Trees
1
2018
60
0.140
Why?
Amino Acids
2
2020
513
0.140
Why?
Antibiotic Prophylaxis
1
2019
133
0.140
Why?
Macrophages
1
2026
1530
0.140
Why?
Antimetabolites, Antineoplastic
1
2018
108
0.140
Why?
Cysteine
1
2019
210
0.130
Why?
Lymphoma
2
2017
251
0.130
Why?
Fusion Proteins, bcr-abl
2
2014
68
0.130
Why?
HLA-DR Antigens
1
2018
211
0.130
Why?
Confidence Intervals
1
2018
328
0.130
Why?
Hematinics
1
2017
22
0.120
Why?
Mediastinal Neoplasms
1
2017
54
0.120
Why?
AMP-Activated Protein Kinases
1
2018
192
0.120
Why?
Infusions, Intravenous
1
2018
429
0.120
Why?
Hedgehog Proteins
1
2018
194
0.120
Why?
Periodicals as Topic
1
2019
209
0.120
Why?
Ataxia Telangiectasia Mutated Proteins
1
2016
69
0.120
Why?
Unrelated Donors
1
2016
39
0.120
Why?
Registries
3
2025
2382
0.120
Why?
Genome, Human
1
2018
425
0.120
Why?
Glucosephosphate Dehydrogenase
1
2016
70
0.120
Why?
Cohort Studies
5
2022
6045
0.120
Why?
Pyrimidines
2
2017
530
0.120
Why?
Energy Metabolism
2
2019
930
0.110
Why?
Geriatric Assessment
1
2018
238
0.110
Why?
NF-E2-Related Factor 2
1
2016
96
0.110
Why?
Oncogene Proteins
1
2016
61
0.110
Why?
Nitriles
1
2017
211
0.110
Why?
Mice, Inbred NOD
4
2019
598
0.110
Why?
Receptor-Interacting Protein Serine-Threonine Kinases
1
2015
13
0.110
Why?
Methyltransferases
1
2016
73
0.110
Why?
Lipopolysaccharides
1
2019
861
0.110
Why?
Myeloid-Lymphoid Leukemia Protein
1
2016
72
0.110
Why?
Genetic Predisposition to Disease
2
2022
2455
0.110
Why?
Programmed Cell Death 1 Receptor
1
2017
268
0.110
Why?
Oligomycins
1
2014
7
0.110
Why?
Biomarkers
3
2022
4329
0.110
Why?
Chromosome Aberrations
1
2015
167
0.110
Why?
Hemoglobins
2
2018
384
0.110
Why?
Mitochondrial Proton-Translocating ATPases
1
2014
23
0.110
Why?
Adolescent
7
2024
22451
0.110
Why?
In Situ Hybridization, Fluorescence
1
2015
333
0.100
Why?
Homeostasis
1
2018
646
0.100
Why?
Electronic Health Records
1
2023
1208
0.100
Why?
Calcineurin Inhibitors
1
2014
67
0.100
Why?
Necrosis
1
2015
243
0.100
Why?
Histone-Lysine N-Methyltransferase
1
2016
141
0.100
Why?
Cells, Cultured
5
2019
4112
0.100
Why?
Vidarabine
2
2018
32
0.100
Why?
Harringtonines
1
2013
2
0.100
Why?
Tumor Suppressor Proteins
1
2016
314
0.100
Why?
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
2013
1
0.100
Why?
Predictive Value of Tests
1
2019
2097
0.100
Why?
Alemtuzumab
3
2007
15
0.100
Why?
Interleukin-1
1
2017
960
0.100
Why?
Gene Expression Profiling
3
2019
1790
0.090
Why?
Glucose
1
2018
1051
0.090
Why?
Pyridazines
1
2013
56
0.090
Why?
Carbon Monoxide
1
2013
82
0.090
Why?
Gene Expression Regulation, Neoplastic
1
2018
1429
0.090
Why?
Nausea
1
2012
111
0.090
Why?
5-Methylcytosine
1
2012
24
0.090
Why?
Biopsy
1
2015
1073
0.090
Why?
Vomiting
1
2012
131
0.090
Why?
Liver
1
2020
1859
0.090
Why?
Membrane Proteins
1
2018
1130
0.090
Why?
Imidazoles
1
2013
244
0.090
Why?
Core Binding Factor Alpha 2 Subunit
2
2023
32
0.080
Why?
Incidence
2
2016
2910
0.080
Why?
Amino Acid Sequence
2
2015
2088
0.080
Why?
Sesquiterpenes
2
2016
51
0.080
Why?
Oxidants
1
2011
100
0.080
Why?
Dioxygenases
1
2010
36
0.080
Why?
Software
1
2015
673
0.080
Why?
Fatigue
1
2012
362
0.080
Why?
GTP-Binding Proteins
1
2011
150
0.080
Why?
Length of Stay
1
2016
1342
0.080
Why?
Chronic Disease
1
2016
1824
0.080
Why?
Wasp Venoms
1
2009
4
0.080
Why?
Ethanol
1
2015
629
0.080
Why?
Insulin Resistance
1
2018
1247
0.080
Why?
Protein Multimerization
1
2011
201
0.070
Why?
Blast Crisis
2
2025
34
0.070
Why?
Injections, Subcutaneous
1
2009
170
0.070
Why?
Hydrogen Peroxide
1
2011
337
0.070
Why?
Mice, Transgenic
3
2023
2131
0.070
Why?
Epinephrine
1
2009
160
0.070
Why?
Immunization Schedule
1
2010
186
0.070
Why?
Adjuvants, Immunologic
1
2010
243
0.070
Why?
Emergencies
1
2009
173
0.070
Why?
RNA, Small Interfering
3
2016
630
0.070
Why?
Melphalan
1
2007
43
0.070
Why?
Inflammation
1
2019
2915
0.060
Why?
Phosphorylation
2
2025
1717
0.060
Why?
Tumor Cells, Cultured
2
2022
878
0.060
Why?
Transplantation Chimera
1
2007
57
0.060
Why?
Blood Transfusion
2
2020
393
0.060
Why?
Karnofsky Performance Status
1
2006
37
0.060
Why?
Nicotinamide Phosphoribosyltransferase
1
2026
26
0.060
Why?
Cell Differentiation
2
2026
1979
0.060
Why?
HEK293 Cells
2
2019
746
0.060
Why?
Disease Models, Animal
3
2026
4565
0.060
Why?
Protein-Tyrosine Kinases
3
2014
429
0.060
Why?
Receptors, Thrombopoietin
2
2016
6
0.060
Why?
Mice, Inbred C57BL
4
2020
6021
0.060
Why?
Evidence-Based Medicine
1
2010
727
0.060
Why?
Calreticulin
2
2016
22
0.060
Why?
Janus Kinase 2
2
2016
31
0.060
Why?
Exome
2
2018
232
0.060
Why?
Ganciclovir
1
2006
51
0.060
Why?
Valine
1
2006
84
0.060
Why?
Acyclovir
1
2006
97
0.060
Why?
Philadelphia Chromosome
2
2016
18
0.050
Why?
Cell Proliferation
3
2020
2497
0.050
Why?
Granulocyte Colony-Stimulating Factor
1
2025
90
0.050
Why?
Risk Factors
3
2014
10840
0.050
Why?
Bone Marrow Transplantation
1
2006
298
0.050
Why?
Phagocytosis
1
2026
298
0.050
Why?
Pedigree
2
2015
507
0.050
Why?
Janus Kinases
2
2015
21
0.050
Why?
Oxidation-Reduction
2
2019
1075
0.050
Why?
Cytomegalovirus Infections
1
2006
203
0.050
Why?
Diamines
1
2023
5
0.050
Why?
Antigens, CD34
1
2023
89
0.050
Why?
para-Aminobenzoates
1
2023
8
0.050
Why?
Chemotaxis
1
2023
121
0.050
Why?
Xenograft Model Antitumor Assays
2
2016
928
0.050
Why?
Flow Cytometry
2
2018
1160
0.050
Why?
Aniline Compounds
1
2023
120
0.050
Why?
Angiogenesis Inhibitors
1
2004
238
0.040
Why?
Pyrrolidines
1
2023
126
0.040
Why?
Breast Neoplasms
1
2015
2411
0.040
Why?
Practice Guidelines as Topic
1
2010
1581
0.040
Why?
Neutropenia
1
2022
153
0.040
Why?
Drug Interactions
2
2013
403
0.040
Why?
Benzodiazepines
1
2023
156
0.040
Why?
Recombinant Proteins
1
2025
1361
0.040
Why?
Early Termination of Clinical Trials
1
2021
18
0.040
Why?
Quinuclidines
1
2020
11
0.040
Why?
Clinical Trials, Phase II as Topic
1
2020
74
0.040
Why?
Hyperbilirubinemia
1
2020
11
0.040
Why?
Receptors, Cell Surface
1
2022
371
0.040
Why?
Neoplasms, Second Primary
1
2021
103
0.040
Why?
Antiviral Agents
1
2006
774
0.040
Why?
Machine Learning
1
2025
590
0.040
Why?
Proportional Hazards Models
2
2017
1318
0.040
Why?
Lentivirus
1
2019
61
0.040
Why?
Disease Susceptibility
1
2021
339
0.040
Why?
Mice, Nude
2
2015
665
0.040
Why?
Daunorubicin
1
2018
25
0.040
Why?
Consolidation Chemotherapy
1
2018
11
0.040
Why?
Maintenance Chemotherapy
1
2018
41
0.030
Why?
Multicenter Studies as Topic
1
2020
413
0.030
Why?
Myeloablative Agonists
1
2018
23
0.030
Why?
Mice, SCID
1
2019
360
0.030
Why?
Datasets as Topic
1
2018
120
0.030
Why?
Mice, Knockout
2
2016
3121
0.030
Why?
Iron
1
2020
359
0.030
Why?
Cause of Death
1
2020
455
0.030
Why?
Fetal Blood
1
2020
325
0.030
Why?
Forkhead Transcription Factors
1
2019
208
0.030
Why?
Whole-Body Irradiation
1
2018
73
0.030
Why?
Cell Count
1
2018
315
0.030
Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
1
2017
16
0.030
Why?
HLA Antigens
1
2019
241
0.030
Why?
Antineoplastic Agents, Immunological
1
2020
200
0.030
Why?
Biological Transport
1
2018
423
0.030
Why?
Child
2
2024
22638
0.030
Why?
Tumor Stem Cell Assay
1
2017
33
0.030
Why?
Glutathione
1
2019
369
0.030
Why?
Clinical Decision-Making
1
2021
364
0.030
Why?
Retinal Dehydrogenase
1
2017
27
0.030
Why?
Combined Modality Therapy
1
2020
1269
0.030
Why?
Diet, High-Fat
1
2018
267
0.030
Why?
Arsenicals
1
2017
28
0.030
Why?
Oxides
1
2017
47
0.030
Why?
Glycolysis
1
2018
341
0.030
Why?
Benzothiazoles
1
2016
39
0.030
Why?
NADP
1
2016
52
0.030
Why?
Heterografts
1
2017
143
0.030
Why?
Hydrazines
1
2016
37
0.030
Why?
Adenosine Triphosphate
1
2019
494
0.030
Why?
Kinetics
1
2019
1553
0.030
Why?
Drug Monitoring
1
2020
399
0.030
Why?
Myeloid Ecotropic Viral Integration Site 1 Protein
1
2016
11
0.030
Why?
Deoxyglucose
1
2016
51
0.030
Why?
Cyclophosphamide
1
2017
275
0.030
Why?
Receptors, Interleukin-1
1
2017
211
0.030
Why?
Reactive Oxygen Species
1
2019
610
0.030
Why?
Sample Size
1
2016
123
0.030
Why?
Sequence Analysis, RNA
1
2018
441
0.030
Why?
Drug Combinations
1
2017
399
0.030
Why?
p38 Mitogen-Activated Protein Kinases
1
2017
262
0.030
Why?
Isoenzymes
1
2016
294
0.030
Why?
Transcriptome
1
2022
1066
0.030
Why?
Positron-Emission Tomography
1
2017
342
0.030
Why?
Splenomegaly
1
2015
15
0.030
Why?
Intercellular Signaling Peptides and Proteins
1
2017
372
0.030
Why?
Colorado
1
2025
4588
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2017
384
0.030
Why?
Repressor Proteins
1
2018
428
0.030
Why?
Dihydrolipoyllysine-Residue Acetyltransferase
1
2014
6
0.030
Why?
Ketone Oxidoreductases
1
2014
7
0.030
Why?
Hydroxyurea
1
2015
35
0.030
Why?
Comorbidity
2
2013
1652
0.030
Why?
Metabolome
1
2018
390
0.030
Why?
Fluorescent Antibody Technique
1
2015
345
0.030
Why?
Diagnosis, Differential
1
2019
1500
0.030
Why?
Interleukin-1beta
1
2017
394
0.030
Why?
Lipid Metabolism
1
2018
533
0.030
Why?
Membrane Potential, Mitochondrial
1
2014
74
0.030
Why?
Imatinib Mesylate
1
2014
77
0.030
Why?
Sirolimus
1
2016
282
0.030
Why?
Immunologic Factors
1
2017
244
0.030
Why?
Sequence Homology, Amino Acid
1
2015
382
0.030
Why?
Health Services Accessibility
1
2023
1101
0.030
Why?
Superoxides
1
2014
198
0.030
Why?
Dasatinib
1
2014
58
0.030
Why?
Quality of Life
2
2016
3187
0.030
Why?
Structure-Activity Relationship
1
2015
561
0.030
Why?
Age of Onset
1
2015
557
0.030
Why?
Genetic Heterogeneity
1
2014
66
0.020
Why?
Trans-Activators
1
2016
371
0.020
Why?
Thiazoles
1
2014
139
0.020
Why?
Research Design
1
2020
1139
0.020
Why?
Leukemia, Lymphoid
1
2013
27
0.020
Why?
Up-Regulation
1
2016
840
0.020
Why?
Drug Synergism
1
2014
353
0.020
Why?
Cyclosporine
1
2014
256
0.020
Why?
Pulmonary Diffusing Capacity
1
2013
78
0.020
Why?
RNA Interference
1
2014
470
0.020
Why?
Mice, Inbred BALB C
1
2015
1244
0.020
Why?
Polymorphism, Single Nucleotide
1
2020
2228
0.020
Why?
Homeodomain Proteins
1
2016
525
0.020
Why?
Cost-Benefit Analysis
1
2015
632
0.020
Why?
Leupeptins
1
2011
13
0.020
Why?
HL-60 Cells
1
2011
29
0.020
Why?
Respiratory Function Tests
1
2013
543
0.020
Why?
Thrombosis
1
2015
397
0.020
Why?
Cysteine Proteinase Inhibitors
1
2011
48
0.020
Why?
Proteasome Inhibitors
1
2011
42
0.020
Why?
Mitoxantrone
1
2010
14
0.020
Why?
Free Radical Scavengers
1
2011
81
0.020
Why?
Molecular Sequence Data
1
2015
2835
0.020
Why?
Genotype
1
2015
1866
0.020
Why?
Etoposide
1
2010
169
0.020
Why?
Neoplasms, Experimental
1
2011
163
0.020
Why?
Acetylcysteine
1
2011
139
0.020
Why?
Mutagenesis, Site-Directed
1
2011
369
0.020
Why?
Proteasome Endopeptidase Complex
1
2011
155
0.020
Why?
Prospective Studies
2
2016
8087
0.020
Why?
Models, Biological
1
2017
1758
0.020
Why?
Treatment Failure
1
2010
358
0.020
Why?
Prevalence
1
2016
2852
0.020
Why?
Insulin
1
2018
2524
0.020
Why?
RNA-Binding Proteins
1
2011
463
0.020
Why?
Nitroimidazoles
1
2004
16
0.010
Why?
Cyclohexanes
1
2004
21
0.010
Why?
Fluorescein
1
2004
23
0.010
Why?
In Situ Nick-End Labeling
1
2004
120
0.010
Why?
Radiation-Sensitizing Agents
1
2004
43
0.010
Why?
Lectins
1
2004
44
0.010
Why?
Neoplasm Transplantation
1
2004
238
0.010
Why?
In Situ Hybridization
1
2004
317
0.010
Why?
Microcirculation
1
2004
142
0.010
Why?
Angiography
1
2004
206
0.010
Why?
Capillaries
1
2004
123
0.010
Why?
Antibiotics, Antineoplastic
1
2004
140
0.010
Why?
Wilms Tumor
1
2004
90
0.010
Why?
Neovascularization, Pathologic
1
2004
285
0.010
Why?
Vascular Endothelial Growth Factor A
1
2004
543
0.010
Why?
Immunohistochemistry
1
2004
1709
0.010
Why?
Hypoxia
1
2004
1209
0.010
Why?
Pollyea's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)